Biggest Seed, Series A-E and Venture Investments within Oncology May 2024.
View the report at the bottom of this page.
May 2024 Snapshot:
186 Companies across EU and US were involved in some sort of cash movements (all indications, all cash types). From this $ 3,429,771,999 total true investment received in USA and EU within the Oncology sector in March 2024 across 53 different biotechs.
Some Notable True Oncology Investments
✅ AttoviaTherapeutics - $105,000,000 (Series B): 2x in preclinical, further developmentof platform
✅ LyciaTherapeutics - $107,000,000 (Series C): Advancing lead programs inautoimmune and inflammatory diseases
✅ AjaxTherapeutics - $95,000,000 (Series C): Beginning of 1st clinical trial
✅ GreyWolf Therapeutics - $50,000,000 (Series B) : 1x Phase ½ clinical trial, expansion of antigen modulation technology
✅ PheonTherapeutics - $120,000,000 (Series B): clinical development pathway for firstthree ADC assets
✅ Plus 43 more in the report
For full report:
Email us: charles@discera-search.com
